Compliance with antihypertensive therapy: Raising the bar of expectations

American Journal of Managed Care

Volumn 4, Issue 7, 1998, Pages 957-966

  Rudd, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CLINICAL EXAMINATION; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; HYPERTENSION; MANAGED CARE PROGRAMS; PATIENT COMPLIANCE; PATIENT EDUCATION; UNITED STATES;

EID: 0031831038     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Kannel WB. Clinical misconceptions dispelled by epidemiologic research. Circulation 1995;92:3350-3360.
2. Sackett D. Hypertension in the real world: Public reaction, physician response, and patient compliance. In: Genest J, Koiw E, Kuchel O, eds. Hypertension: Physiology and Treatment. New York: McGraw-Hill; 1979:1142-1149.
3. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
4. Weber MA. The evolving paradigm of hypertension. Cardiol Clin 1995;13:473-478.
5. Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979:1-7.
6. Levine M: Costs associated with noncompliance. In: Leenen FH, ed. Patient Compliance and the Long-Term Management of Hypertension. Pointe-Claire, Quebec: STA Communications; 1996:21-28.
7. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: A study of a United Kingdom population. Br Med J 1995;311:293-295.
8. Lip GY, Beevers DG. Doctors, nurses, pharmacists and patients - the Rational Evaluation and Choice in Hypertension (REACH) survey of hypertension care delivery. Blood Press Suppl 1997;1:6-10.
9. Calkins DR, Davis RB, Reiley P, et al. Patient-physician communication at hospital discharge and patient's understanding of the postdischarge treatment plan. Arch Intern Med 1997;157:1026-1030.
10. Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of screening mammography. J Med Screen 1994;1:7-12.
11. Ley P. Doctor-patient communication: Some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens 1985;3(suppl):S51-S55.
12. Blackwell B. The drug defaulter. Clin Pharmacol Ther 1972;13:841-848.
13. Blackwell B. Drug therapy: Patient compliance. N Engl J Med 1973;289:249-252.
14. Haynes RB. Determinants of compliance: The disease and the mechanisms of treatment. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979:49-62.
15. Haynes RB, Taylor DW, Sackett DL. Categorical tables of factors studied in relation to compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979:454-474.
16. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 1996;19:1153-1164.
17. Holm S. What is wrong with compliance? J Med Ethics 1993;19:108-110.
18. Carlberg A. Patient satisfaction and design of treatment. Results from a study of two different ways of treating hypertension. Scand J Prim Health Care 1993;11:105-110.
19. Lorenc L, Branthwaite A. Are older adults less compliant with prescribed medication than younger adults? Br J Clin Psychol 1993;32:485-492.
20. Daltroy LH. Doctor-patient communication in rheumatological disorders. Baillieres Clin Rheumatol 1993;7: 221-239.
21. Ong LM, de Haes JC, Haes AM, Lammes FB. Doctor-patient communication: A review of the literature. Soc Sci Med 1995;40:903-918.
22. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care 1987;2:23-35.
23. Eisen SA, Hanpeter JA, Kreuger LW, Gard M. Monitoring medication compliance: Description of a new device. J Compliance Health Care 1987;2:131-142.
24. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-3277.
25. Kruse W, Koch-Gwinner P, Nikolaus T, et al. Measurement of drug compliance by continuous electronic monitoring: A pilot study in elderly patients discharged from hospital. J Am Geriatr Soc 1992;40:1151-1155.
26. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacological indicator to compare compliance with tablets prescribed once, twice, or three times daily. Clin Pharmacol Ther 1988;44:540-545.
27. Park LC, Lipman RS. A comparison of patient dosage deviation reports with pill counts. Psychopharmacologica 1964;6:299-302.
28. Rickels K, Briscoe F. Assessment of dosage deviation in outpatient drug research. J Clin Pharmacol 1970;10: 153-160.
29. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: Is self-report the best available measure? Med Care 1981;19:1061-1064.
30. Gordis L, Markowitz M, Lilienfeld AM. The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care 1969;7:49-54.
31. Weintraub M, Au WYW, Lasagna L. Compliance as a determinant of serum digoxin concentration. JAMA 1973;224:481-485.
32. Paulsen SM, Krause S, Iber FL. Development and evaluation of a compliance test for patients taking disulfiram. Johns Hopkins Med J 1977;141:119-125.
33. Enlund H, Tuomilehto J, Turakka H. Patient report validated against prescription records for measuring use of and compliance with antihypertensive drugs. Acta Med Scand 1981;209:271-275.
34. Joyce CRB. Patient cooperation and the sensitivity of clinical trials. J Chronic Dis 1962;15:1025-1036.
35. Finney JW, Friman PC, Rapoff MA, Christophersen ER. Improving compliance with antibiotic regimens for otitis media. Am J Dis Child 1985;139:89-95.
36. Mushlin AI, Appel FA. Diagnosing patient noncompliance. Arch Intern Med 1977;137:318-321.
37. Moulding TS. The unrealized potential of the medication monitor. Clin Pharmacol Ther 1979;25:131-136.
38. Norell SE. Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med (E) 1981;15:57-61.
39. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-764.
40. Craig HM. Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health 1985;8:61-66.
41. Maenpaa H, Javela K, Pikkarainen J, et al. Minimal doses of digoxin: A new marker for compliance to medication. Eur Heart J 1987;8:31-37.
42. Hosie J, Wiklund I. Managing hypertension in general practice: Can we do better? J Hum Hypertens 1995;9: S15-S18.
43. Rosner B, Polk B. The implications of blood pressure variability for clinical screening purposes. J Chronic Dis 1979;32:451-461.
44. Taylor D, Sackett D, Haynes R, et al. Compliance with antihypertensive drug therapy. Ann NY Acad Sci 1978; 304:390-403.
45. Sackett DL, Haynes RB, Tugwell P. Compliance. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown & Co; 1985:199-222.
46. Silas JH, Tucker GT, Smith AJ. Drug resistance, inappropriate dosing and non-compliance in hypertensive patients. Br J Clin Pharmacol 1980;9:427-430.
47. Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol 1987;5:1469-1476.
48. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990;8:356-364.
49. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988;20:63-69.
50. Schweizer RT, Rovelli M, Palmeri D, et al. Noncompliance in organ transplant recipients. Transplantation 1990; 49:374-377.
51. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF. Antihypertensive medication-taking: Investigation of a simple regimen. Am J Hypertens 1993;6:586-592.
52. Dodrill CB, Batzel LW, Wilensky AJ, Yerby MS. The role of psychosocial and financial factors in medication noncompliance in epilepsy. Int J Psychiatry Med 1987;17:143-154.
53. Wallenius SH, Vainio KK, Korhonen MJ, Hartzema AG, Enlund HK. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother 1995;29:1213-1217.
54. Rudd P. Maximizing compliance with antihypertensive therapy. Drug Ther 1992;22:25-32.
55. Cramer JA. Identifying and improving compliance patterns: A composite plan for health care providers. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991:387-392.
56. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515-523.
57. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986;101:524-530.
58. Gordon ME, Kass MA. Validity of standard compliance measures in glaucoma compared with an electronic eyedrop monitor. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991:163-173.
59. Rudd P, Ramesh J, Bryant-Kosling C, Guerrero D. Gaps in cardiovascular medication taking: The tip of the iceberg. J Gen Intern Med 1993;8:659-666.
60. Cramer J, Vachon L, Desforges C, Sussman NM. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995;36:1111-1117.
61. Wasson J, Gaudette C, Whaley F, et al. Telephone care as a substitute for routine clinic follow-up. JAMA 1992; 267:1788-1793.
62. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996;9:285-292.
63. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-729.
64. DeBusk RF. MULTIFIT: A new approach to risk factor modification. Cardiol Clin 1996;14:143-157.
65. Taylor CB, Miller NH, Smith PM, DeBusk RF. The effect of a home-based, case-managed, multifactorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease. J Cardiopulm Rehabil 1997;17:157-162.
66. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997;79:58-63.